Indications for: ROCKLATAN

Open-angle glaucoma. Ocular hypertension.

Adult Dosage:

Instill 1 drop into the affected eye(s) once daily in the PM.

Children Dosage:

Not established.

ROCKLATAN Warnings/Precautions:

Do not exceed recommended dose. Ocular inflammation; avoid if active. Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Herpetic keratitis; avoid if active. Concurrent corneal disease or disruption of the ocular epithelial surface. Contact lenses (remove; may reinsert lenses 15mins after administration). Pregnancy. Nursing mothers.

ROCKLATAN Classification:

Rho kinase inhibitor + prostaglandin analogue.

ROCKLATAN Interactions:

Allow at least 5mins between administration of thimerosal-containing oph drops or other topical oph agents. Concomitant additional prostaglandins or prostaglandin analogues: not recommended.

Adverse Reactions:

Conjunctival hyperemia, instillation site pain, corneal verticillata, conjunctival hemorrhage, eye pruritus, reduced visual acuity, increased lacrimation, instillation site discomfort, blurred vision; increased ocular pigmentation (eg, iris, eyelid, eyelashes; may be permanent), eyelash changes, bacterial keratitis.

Generic Drug Availability:


How Supplied: